Corpus Intelligence IC Memo — CENTERSTONE OF FLORIDA INC. 2026-04-26 14:10 UTC
IC Memo — CENTERSTONE OF FLORIDA INC.
Investment Committee Memorandum | FL | 41 beds | Grade D | EBITDA uplift $422K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CENTERSTONE OF FLORIDA INC.

CCN 104040 | MANATEE, FL | 41 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CENTERSTONE OF FLORIDA INC. is a 41-bed community hospital in MANATEE, FL with $5.6M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 17.3% Medicare, 0.0% Medicaid, and 82.7% commercial.

Thesis: Turnaround. Our ML models identify $422K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -239.6% (+756bps).

Net Revenue HCRIS$5.6M
Current EBITDA COMPUTED$-13.8M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS59.2%
Revenue / Bed COMPUTED$136K
Net-to-Gross HCRIS45.7%
Distress Probability MLnan%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
79
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of -100.0% places it below the state median. Among 79 size-comparable peers (20-82 beds), the median margin is 2.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-82), prioritizing same-state peers. 79 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CENTERSTONE OF FLORIDA INC. (Target)FL41$5.6M-100.0%
ASCENSION SACRED HEART EMERALDFL80$187.9M16.1%
GULF BREEZE HOSPITALFL65$121.8M12.8%
OVIEDO MEDICAL CENTERFL64$110.9M7.4%
BARTOW REGIONAL MEDICAL CENTERFL72$90.9M11.3%
BAPTIST MEDICAL CTR-NASSAUFL54$85.1M2.1%
HCA FLORIDA PUTNAM HOSPITALFL82$82.7M11.5%
UCF LAKE NONA HOSPITALFL64$80.3M1.8%
BAYFRONT HEALTH PUNTA GORDAFL82$78.7M3.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $422K (756bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$117K+210bp18mo
Denial Rate Reduction12.0%6.5%$116K+207bp12mo
Cost to Collect4.5%2.5%$112K+200bp12mo
A/R Days Reduction5200.0%3800.0%$68K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+17bp6mo

5. EBITDA Bridge

Net Collection Rate
$117K
Denial Rate Reduction
$116K
Cost to Collect
$112K
A/R Days Reduction
$68K
Clean Claim Rate
$10K
Total EBITDA Uplift$422K
Current EBITDA$-13.8M
+ RCM Uplift+$422K
Pro Forma EBITDA$-13.4M
Current Margin-100.0%
Pro Forma Margin-239.6%
WC Released (1x)$214K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-21.2M$-86.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-21.2M$-102.3M0.00x-100.0%
Bull Case9.0x11.0x$-19.1M$-107.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-19.1M$-123.2M0.00x-100.0%
Bear Case11.0x10.0x$-23.3M$-81.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-23.3M$-97.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 79 hospitals with 20-82 beds
  • Same-state prioritization (n=80)
  • Comp margins: P25=-18.6% / P50=2.2% / P75=11.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.